Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
This dual capability has made Southend a significant player in the compounded GLP-1 medication space, partnering with telehealth platforms and clinics across approximately 35 states
Glycaemic outcomes were equally striking: 7782% of participants on retatrutide achieved euglycaemia (HbA1c 6.5%), and between 5763% achieved body weight reductions of 15% or more
The version without DAC (Drug Affinity Complex) has a half life of roughly 30 minutes, producing controlled bursts that closely mimic natural physiology
Its systemic effects make it useful for broader recovery support rather than isolated treatment areas alone
Id ask questions like how long theyd been taking that dose, what their side effects were, and then we would come to a decision together about what dose to start
As a dual agonist, tirzepatide (GLP-1 + GIP) continues to outperform semaglutide in weight loss and metabolic control, setting a new bar for combination therapies
US$ 23.86
US$ 25.88
US$ 28.67
US$ 24.57
US$ 24.44
US$ 24.58
